2023 record year for Johnson & Johnson

Tomorrow the American Johnson & Johnson will report its past quarters results. For this year Johnson & Johnson 's revenue will be around 97.71 billion USD. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is slightly more than 2022's revenue of 94.94 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2023

koersdata

The analysts expect for 2023 a net profit of 27.76 billion USD. According to most of the analysts the company will have a profit per share for this book year of 10.51 USD. Based on this the price/earnings-ratio is 15.78.

For this year most of the analysts expect a dividend of 4.71 USD per share. Thus the dividend yield equals 2.84 percent. The average dividend yield of the pharmaceutical companies is an attractive 2.07 percent.

Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 435.99 billion USD.

Historical stock prices Johnson & Johnson period 2007-2023

financial analysis johnson&johnson

On Friday the stock closed at 165.84 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.